EDAP Schedules Webcast and Conference Call for Third Quarter 2010 Results
October 27 2010 - 8:00AM
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic
ultrasound, announced today the details relating to its third
quarter 2010 results announcement, which will take place on
Wednesday, November 17, 2010, before the opening of the market.
EDAP will hold a conference call on Wednesday, November 17, 2010
at 8:30 a.m. EST to discuss the results. The dial-in numbers are
(877) 407-4134 for domestic callers and (201) 689-8430 for
international. The conference ID number for both is 359599. A live
Webcast of the conference call will be available online from the
investor relations page of the Company's corporate Website at
www.edap-tms.com.
After the live Webcast, the call will remain available on EDAP's
Website, www.edap-tms.com, through December 17, 2010. In addition,
a telephonic replay of the call will be available until November
24, 2010. The replay dial-in numbers are 877-660-6853 for domestic
callers and 201-612-7415 for international callers. Please use
account number 356 and event ID number 359599.
About EDAP TMS SA
EDAP TMS SA develops and markets Ablatherm, the most advanced
and clinically proven choice for high-intensity focused ultrasound
(HIFU) treatment of localized prostate cancer. HIFU treatment is
shown to be a minimally invasive and effective treatment option
with a low occurrence of side effects. Ablatherm-HIFU is generally
recommended for patients with localized prostate cancer (stages
T1-T2) who are not candidates for surgery or who prefer an
alternative option, or for patients who failed radiotherapy
treatment. Approved in Europe as a treatment for prostate cancer,
Ablatherm-HIFU (High Intensity Focused Ultrasound) is currently
undergoing evaluation in a multicenter U.S. Phase II/III clinical
trial under an Investigational Device Exemption granted by the FDA.
The Company also is developing this technology for the potential
treatment of certain other types of tumors. EDAP TMS SA also
produces and commercializes medical equipment for treatment of
urinary tract stones using extra-corporeal shockwave lithotripsy
(ESWL). For more information on the company, please visit
http://www.edap-tms.com, http://www.hifu-planet.com.
CONTACT: EDAP TMS SA
Blandine Confort, Investor Relations/Legal Affairs
+33 4 72 15 31 72
bconfort@edap-tms.com
The Ruth Group
Investors:
Stephanie Carrington
646-536-7017
scarrington@theruthgroup.com
EDAP TMS (NASDAQ:EDAP)
Historical Stock Chart
From Jun 2024 to Jul 2024
EDAP TMS (NASDAQ:EDAP)
Historical Stock Chart
From Jul 2023 to Jul 2024